Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Astrazeneca (AZN) Share News

LONDON BROKER RATINGS: UBS raises AstraZeneca; RBC cuts Bunzl

12th Jul 2023 09:27

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday: Read More

LONDON MARKET OPEN: FTSE 100 higher as UK banks pass BoE stress tests

12th Jul 2023 08:45

(Alliance News) - European markets were trading higher on Wednesday, in a sign of cautious optimism ahead of US inflation data. Read More

LONDON BRIEFING: UK banks pass stress test; Wetherspoon trades well

12th Jul 2023 07:40

(Alliance News) - Stocks in London are called higher on Wednesday, ahead of US inflation data. Read More

LONDON MARKET CLOSE: FTSE 100 ends rough week in tepid fashion

7th Jul 2023 16:55

(Alliance News) - Stock prices in Europe diverged on Friday, with the FTSE 100 underperforming, as a weaker-than-expected US jobs report did little for equities amid the expectation that the Federal is not done with hiking. Read More

LONDON BROKER RATINGS: UBS likes Pearson; Liberum cuts Naked Wine

5th Jul 2023 09:34

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday: Read More

LONDON MARKET CLOSE: Tepid close after quiet day with US market closed

4th Jul 2023 16:49

(Alliance News) - Stocks in London were largely higher on Tuesday, though the FTSE 100 slipped into the red amid weakness, while US markets were shut for the independence day holiday. Read More

LONDON MARKET MIDDAY: Stocks higher amid US holiday-thinned trade

4th Jul 2023 12:08

(Alliance News) - Stock prices in London were higher at midday on Tuesday, with the absence of US markets and any major economic releases keeping trade muted. Read More

LONDON BROKER RATINGS: Dunelm, AstraZeneca and Persimmon cut

4th Jul 2023 09:27

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday: Read More

AstraZeneca shares fall as lung cancer results not as strong as hoped

3rd Jul 2023 18:26

(Alliance News) - AstraZeneca PLC on Monday saw shares fall, as test results suggested a new lung cancer drug may be less successful than hoped, despite being generally positive. Read More

LONDON MARKET CLOSE: Blue chips lose early shine as US treads water

3rd Jul 2023 17:05

(Alliance News) - London's FTSE 100 ran out of steam on Monday to close little changed, while New York markets made a muted start to an abbreviated session ahead of Independence Day. Read More

LONDON MARKET MIDDAY: Miners and oil majors lead FTSE 100 march

3rd Jul 2023 12:05

(Alliance News) - European equities went into Monday afternoon on the up, with the FTSE 100 outperforming as it was supported by its natural resources sector and oil majors. Read More

LONDON MARKET OPEN: Stocks start second half in green amid PMIs

3rd Jul 2023 09:07

(Alliance News) - European markets rose at Monday's open, kicking off the start of the second half on a positive note, boosted by strong trading in Asia and New York, Read More

TOP NEWS: AstraZeneca, Daiichi hail datopotamab lung cancer trial

3rd Jul 2023 08:42

(Alliance News) - AstraZeneca PLC and Tokyo-based partner Daiichi Sankyo Co Ltd on Monday announced that their investigational antibody drug conjugate Datopotamab deruxtecan showed positive results in an advanced non-small cell lung cancer trial. Read More

IN BRIEF: AstraZeneca invests USD400 million in reforestation

28th Jun 2023 11:54

AstraZeneca PLC - Cambridge-based pharmaceutical company - Announces USD400 million investment in global AZ Forest programme, aiming to plant 50 million trees by the end of 2025 and 200 million trees by 2030. Projects are in Brazil, India, Vietnam, Ghana and Rwanda. The programme is focused on reforestation, biodiversity and community resilience and spans over 100,000 hectares worldwide. Read More

AstraZeneca's diabetes combination treatment approved in China

27th Jun 2023 08:19

(Alliance News) - AstraZeneca PLC on Tuesday said its Xigduo XR combination treatment has received approval in China for type-2 diabetes. Read More

EU committee recommends expanded approval for AstraZeneca's Soliris

26th Jun 2023 08:39

(Alliance News) - AstraZeneca PLC on Monday said Soliris has been recommended for marketing authorisation in the EU for expanded use in generalised myasthenia gravis, gMG. Read More

China spin-off may allow AstraZeneca to avoid "regulatory clampdown"

19th Jun 2023 10:50

(Alliance News) - The Financial Times reported on Monday that AstraZeneca PLC has drafted plans to separate its China business amid geopolitical tensions. Read More

LONDON MARKET OPEN: Stocks falter amid weaker outlook for China

19th Jun 2023 09:09

(Alliance News) - Stock prices in London opened lower on Monday, ahead of more interest rate decisions, and amid fears for China's slowing economic recovery. Read More

LONDON BRIEFING: Severn Trent deal sized up by CMA; Coca-Cola HBC buys

19th Jun 2023 07:53

(Alliance News) - Stocks in London are called lower on Monday, ahead of more central bank decisions, while a meeting between US Secretary of State Antony Blinken and his Chinese counterpart put relations between the two nations back under the spotlight. Read More

PRESS: AstraZeneca drafts plan to spin-off in China - FT

19th Jun 2023 07:00

(Alliance News) - AstraZeneca PLC has drafted plans to separate its China business amid geopolitical tensions, the Financial Times reported on Monday. Read More

FTSE 100 Latest

Value10,600.53

Change-2.95